Skip Nav Destination
Ask the Hematologists
Since monoclonal B-cell lymphocytosis is frequently encountered in hematologic practice, a detailed discussion of that condition is warranted. Read More
Latest Articles

President's Column
With an Eye on Quality, ASH to Launch New Journals
Aug 17, 2023
In January, ASH plans to launch two peer-reviewed journals: Blood Neoplasia and Blood Vessels, Thrombosis & Hemostasis (VTH). Learn what readers can expect.
Featured Content

Mentoring Makes the Difference
Four mentor-mentee pairs share their experiences as part of a program under ASH’s Minority Recruitment Initiative, which turns 20 this year.

MEN1 Mutations Induce Acquired Resistance to the Menin Inhibitor Revumenib
Contributing Editor Christine McMahon, MD, shares her insights on a study that assesses the mechanisms underlying acquired resistance to revumenib.

Rilzabrutinib for Persistent ITP: New Kid on the Block?
Researchers are studying the efficacy of rilzabrutinib for the treatment of primary, persistent immune thrombocytopenia.